Info

Blue Heron Biotechnology has been a pioneer and leader of the gene synthesis market since its founding in 1999. Blue Heron provides the broadest range of synthetic DNA sequences and related services to thousands of researchers across multiple industries, including 19 of the top 20 pharmaceutical and biotechnology companies. With its proprietary GeneMaker® technology, Blue Heron regularly produces perfect DNA sequences from the simplest to the most complex structures and from 60 base pairs to well over 20,000 base pairs in length including the first synthetic DNA fragment over 50,000 base pairs. Unlike other company's approaches which rely on adaptations of standard PCR, Blue Heron's GeneMaker® platform includes proprietary design software which considers multiple characteristic of each section of the target DNA sequence and optimally builds each section using multiple, proprietary process technologies. This way, Blue Heron successfully completes projects where other company's standard processes have failed. Researchers from the leading pharmaceutical and biotechnology companies as well as emerging synthetic biology, BioFuels, and "clean tech" companies choose Blue Heron for their unmatched technological capability, quality of customer service, and long record of success and industry leadership. The demand for perfect DNA sequences is growing geometrically and research projects are becoming much more complex. Blue Heron has the experience and technological capability to meet this demand today and into the future.